Literature DB >> 3097031

Structure and function of human tissue-type plasminogen activator (t-PA).

A J van Zonneveld, H Veerman, M E MacDonald, J A van Mourik, H Pannekoek.   

Abstract

Full-length tissue-type plasminogen activator (t-PA) cDNA served to construct deletion mutants within the N-terminal "heavy" (H)-chain of the t-PA molecule. The H-chain cDNA consists of an array of structural domains homologous to domains present on other plasma proteins ("finger," "epidermal growth factor," "kringles"). These structural domains have been located on an exon or a set of exons. The endpoints of the deletions nearly coincide with exon-intron junctions of the chromosomal t-PA gene. Recombinant t-PA deletion mutant proteins were obtained after transient expression in mouse Ltk- cells, transfected with SV40-pBR322-derived t-PA cDNA plasmids. It is demonstrated that the serine protease moiety of t-PA and its substrate specificity for plasminogen is entirely contained within the C-terminal "light" (L)-chain of the protein. The presence of cDNA, encoding the t-PA signal peptide preceding the remaining portion of t-PA, suffices to achieve secretion of (mutant) t-PA into the medium. The stimulatory effect of fibrin on the plasminogen activator activity of t-PA was shown to be mediated by the kringle K2 domain and, to a lesser extent, by the finger domain. The other domains on the H-chain, kringle K1, and the epidermal growth-factor-like domain, do not contribute to this property of t-PA. These findings correlate well with the fibrin-binding properties of the rt-PA deletion-mutant proteins, indicating that stimulation of the activity is based on aligning of the substrate plasminogen and its enzyme t-PA on the fibrin matrix. The primary target for endothelial plasminogen activator inhibitor (PAI) is located within the L-chain of t-PA. Deleting specific segments of t-PA H-chain cDNA and subsequent transient expression in mouse Ltk- cells of t-PA deletion-mutant proteins did not affect the formation of a stable complex between mutant t-PA and PAI.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097031     DOI: 10.1002/jcb.240320302

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

1.  Functional and structural characterization of Vibrio cholerae extracellular serine protease B, VesB.

Authors:  Shilpa Gadwal; Konstantin V Korotkov; Jaclyn R Delarosa; Wim G J Hol; Maria Sandkvist
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

2.  Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.

Authors:  T Teesalu; A E Hinkkanen; A Vaheri
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  High resolution structure of human apolipoprotein (a) kringle IV type 2: beyond the lysine binding site.

Authors:  Alice Santonastaso; Maristella Maggi; Hugo De Jonge; Claudia Scotti
Journal:  J Lipid Res       Date:  2020-09-09       Impact factor: 5.922

4.  Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.

Authors:  O F Wagner; C de Vries; C Hohmann; H Veerman; H Pannekoek
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 5.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

6.  Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Authors:  Kathleen A Stringer; Meghan Tobias; John S Dunn; Jackie Campos; Zachary Van Rheen; Mitra Mosharraf; Rajiv Nayar
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

7.  Asn and asn: critical residues for in vitro biological activity of reteplase.

Authors:  Naganath Mandi; Kalyana R Sundaram; Sunil K Tandra; Suman Bandyopadhyay; Sriram Padmanabhan
Journal:  Adv Hematol       Date:  2010-06-21

8.  Expression of active human tissue-type plasminogen activator in Escherichia coli.

Authors:  J Qiu; J R Swartz; G Georgiou
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

9.  tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2.

Authors:  Westley B Nolin; Jaime Emmetsberger; Noreen Bukhari; Yan Zhang; Joel M Levine; Stella E Tsirka
Journal:  Glia       Date:  2008-01-15       Impact factor: 7.452

10.  The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.

Authors:  Samuel N Heyman; Zohair Hanna; Taher Nassar; Ahuva Shina; Sa'ed Akkawi; Marina Goldfarb; Seymour Rosen; Abd-Al Roof Higazi
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.